Peptide Testing Methodology

HPLC and mass spectrometry verification on every batch.

Our Testing Philosophy

At WholesaleBulkPeptides, analytical testing is not an afterthought or a compliance checkbox — it is the central pillar of our quality commitment. Every research peptide we manufacture and distribute undergoes a comprehensive, multi-method analytical testing protocol designed to verify identity, purity, and safety before any product is released to our wholesale customers and private-label partners.

Our testing philosophy rests on three principles: batch-specific testing (every production batch is tested individually — results are never extrapolated from previous batches), multi-method verification (no single analytical technique provides a complete quality picture — we use complementary methods), and full transparency (all test results are documented in batch-specific Certificates of Analysis and made available to every customer).

High-Performance Liquid Chromatography (HPLC)

HPLC is the gold-standard analytical technique for determining peptide purity. Our HPLC testing program quantifies the proportion of the target peptide relative to synthesis byproducts, degradation products, truncated sequences, and other impurities.

Our HPLC protocol:

  • Reverse-phase HPLC (RP-HPLC) — We employ C18 reverse-phase columns, which are the industry standard for peptide purity analysis, providing excellent resolution of closely related impurities.
  • UV detection at 214 nm and 280 nm — Dual-wavelength detection captures both the peptide backbone absorbance (214 nm) and aromatic amino acid absorbance (280 nm) for comprehensive impurity profiling.
  • Gradient elution — Carefully optimized mobile-phase gradients (water/acetonitrile with TFA modifier) ensure separation of the target peptide from structurally similar impurities.
  • Purity threshold — All compounds must meet a minimum 98% HPLC purity to pass quality control. Batches that fall below this threshold are rejected, re-purified, or re-synthesized.
  • Chromatogram documentation — Complete chromatographic data — including retention times, peak areas, and integration parameters — is recorded and included in every Certificate of Analysis.

HPLC purity analysis answers the critical question: “How pure is this sample?” It is the most important quantitative measure of peptide quality and the primary metric cited by researchers and procurement professionals when evaluating suppliers. Learn how to interpret HPLC results in our COA interpretation guide.

Mass Spectrometry (MS) Verification

Mass spectrometry provides definitive molecular identification by measuring the mass-to-charge ratio of peptide ions. While HPLC quantifies purity, MS confirms identity — answering the question: “Is this the correct compound?”

Our MS protocol:

  • Electrospray ionization mass spectrometry (ESI-MS) — Our primary identification method, ESI-MS gently ionizes peptides in solution, producing multiply charged ions that enable accurate molecular-weight determination across a wide mass range.
  • Molecular weight verification — The observed molecular weight must match the theoretical molecular weight (calculated from the amino acid sequence) within ±0.1% tolerance. Any discrepancy triggers investigation for sequence errors, modifications, or contamination.
  • Charge-state analysis — Examination of the charge-state envelope provides additional confidence in molecular identification and can reveal the presence of unexpected adducts or modifications.
  • Spectrum documentation — Complete mass spectra, including observed and theoretical molecular weights, charge states, and instrument parameters, are included in batch-specific COAs.

Mass spectrometry is particularly critical for complex peptides, modified sequences, and compounds where synthesis errors could produce products with similar HPLC profiles but incorrect molecular structures.

Endotoxin Testing

Endotoxins are lipopolysaccharide (LPS) components of gram-negative bacterial cell walls that can contaminate peptide preparations during synthesis, purification, or handling. Even trace levels of endotoxin can confound in-vitro research by activating immune-response pathways in cell-based assays.

Our endotoxin testing protocol:

  • Limulus Amebocyte Lysate (LAL) test — The FDA-recognized standard for endotoxin detection, using reagents derived from horseshoe crab blood cells that coagulate in the presence of endotoxins.
  • Quantitative chromogenic method — We employ the chromogenic LAL method for precise quantification of endotoxin levels, providing exact EU/mg values rather than simple pass/fail determinations.
  • Acceptance criteria — All compounds must test below 1 EU/mg to pass our quality-control release criteria. Products intended for sensitive cell-culture applications undergo additional screening at lower thresholds.
  • Contamination prevention — Our manufacturing facility implements depyrogenation protocols, endotoxin-free consumables, and controlled-environment handling to minimize contamination risk during production.

Amino Acid Analysis

Amino acid analysis (AAA) provides an orthogonal method for verifying peptide composition and concentration. By hydrolyzing the peptide into its constituent amino acids and quantifying each, AAA confirms that the correct amino acids are present in the expected ratios.

  • Acid hydrolysis — Peptides are hydrolyzed under controlled conditions (6N HCl, 110°C, 24 hours) to release individual amino acids.
  • Chromatographic quantification — Released amino acids are derivatized and quantified by HPLC or ion-exchange chromatography, producing a compositional profile.
  • Composition verification — Measured amino acid ratios are compared against theoretical ratios calculated from the target sequence. Deviations indicate sequence errors, truncations, or contamination.
  • Content determination — AAA also provides accurate peptide content (net peptide weight), which is critical for researchers preparing precise concentrations for their experiments.

Batch-Specific Testing Protocol

Every production batch at WholesaleBulkPeptides follows a standardized, documented testing workflow from synthesis through release:

  • In-process testing — During synthesis, coupling efficiency is monitored at each residue addition. Poor coupling efficiency triggers investigation before the synthesis continues.
  • Crude analysis — After synthesis completion, the crude peptide is analyzed by HPLC and MS to assess purity before purification and to guide purification strategy.
  • Post-purification analysis — After HPLC purification, the purified peptide undergoes the complete analytical suite: RP-HPLC purity, ESI-MS identity, LAL endotoxin, and amino acid analysis.
  • Release testing — Final lyophilized product is retested to confirm that the lyophilization process did not affect purity or identity. Only batches passing all release criteria are approved for distribution.
  • COA generation — All analytical data is compiled into a batch-specific Certificate of Analysis through our Laboratory Information Management System (LIMS).
  • Retention samples — A retention sample from each batch is archived under controlled conditions for future reference, stability monitoring, and dispute resolution.

Third-Party Verification

We actively encourage our wholesale partners and customers to submit our products for independent third-party testing. Third-party verification is the highest standard of quality assurance in the peptide industry, and we are confident that independent results will confirm our COA data.

  • Independent lab compatibility — Our COAs include complete method details (column specifications, mobile phases, gradient programs, MS parameters) to enable independent laboratories to reproduce our analytical conditions.
  • Sample availability — We provide additional sample material upon request for customers who wish to submit products for independent analysis.
  • Dispute resolution — In the rare event of a discrepancy between our COA data and third-party results, we initiate a formal investigation including reanalysis of retention samples and comparison of analytical methods.

Our commitment to third-party verification reflects our confidence in our manufacturing and testing processes. We view independent testing not as a threat but as an opportunity to demonstrate the quality that sets us apart in the wholesale peptide market.

Accessing Test Results

All analytical test results are accessible through multiple channels to ensure maximum transparency and convenience:

  • COA Library — Browse our complete Certificate of Analysis library to access COAs by compound name and lot number.
  • Order documentation — Every order ships with printed COAs for each compound and lot included in the shipment.
  • Account portal — Wholesale program members can access all historical COAs through their account dashboard.
  • Custom formats — Private-label customers receive co-branded COAs formatted with their brand identity for distribution to end customers.
  • Direct request — Contact our team to request COAs for any compound or lot number at any time.

Our testing methodology, documentation practices, and commitment to transparency are designed to give researchers, procurement professionals, and brand builders complete confidence in the quality of every compound they source from WholesaleBulkPeptides.